| Frazier Life Sciences Public Fund, L.P. |
8% |
5,738,457 |
0 |
5,738,457 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P., GP of Frazier Life Sciences Public Fund, L.P. |
0001863769 |
| FHMLSP, L.P. |
8% |
5,738,457 |
0 |
5,738,457 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLSP, L.L.C., GP of FHMLSP, L.P. |
0001879466 |
| FHMLSP, L.L.C. |
8% |
5,738,457 |
0 |
5,738,457 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLSP, L.L.C. |
0001879465 |
| Frazier Life Sciences Public Overage Fund, L.P. |
2.2% |
1,531,870 |
0 |
1,531,870 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P., GP of Frazier Life Sciences Public Overage Fund, L.P. |
0001913804 |
| FHMLSP Overage, L.P. |
2.2% |
1,531,870 |
0 |
1,531,870 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C., GP of FHMLSP Overage, L.P. |
0001963247 |
| FHMLSP Overage, L.L.C. |
2.2% |
1,531,870 |
0 |
1,531,870 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLSP Overage, L.L.C. |
0001963248 |
| Frazier Life Sciences X, L.P. |
0.1% |
48,203 |
0 |
48,203 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P., GP of Frazier Life Sciences X, L.P. |
0001790879 |
| FHMLS X, L.P. |
0.1% |
48,203 |
0 |
48,203 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS X, L.L.C., GP of FHMLS X, L.P. |
0001790880 |
| FHMLS X, L.L.C. |
0.1% |
48,203 |
0 |
48,203 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS X, L.L.C. |
0001790811 |
| Frazier Life Sciences XI, L.P. |
1.4% |
961,550 |
0 |
961,550 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P., GP of Frazier Life Sciences XI, L.P. |
0001911592 |
| FHMLS XI, L.P. |
1.4% |
961,550 |
0 |
961,550 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS XI, L.L.C., GP of FHMLS XI, L.P. |
0001911580 |
| FHMLS XI, L.L.C. |
1.4% |
961,550 |
0 |
961,550 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS XI, L.L.C. |
0001911623 |
| Frazier Life Sciences IX, L.P. |
8.3% |
5,827,415 |
0 |
5,827,415 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS IX, L.L.C., GP of FHMLS IX, L.P., GP of Frazier Life Sciences IX, L.P. |
0001720320 |
| FHMLS IX, L.P. |
8.3% |
5,827,415 |
0 |
5,827,415 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS IX, L.L.C., GP of FHMLS IX, L.P. |
0001782789 |
| FHMLS IX, L.L.C. |
8.3% |
5,827,416 |
0 |
5,827,416 |
/s/ Steve R. Bailey |
By Steve R. Bailey, CFO of FHMLS IX, L.L.C. |
0001782791 |
| Frazier Life Sciences XII, L.P. |
0.3% |
223,986 |
0 |
223,986 |
/s/ Gordon Empey |
By Gordon Empey, General Counsel of FHMLS XII, L.L.C., GP of FHMLS XII, L.P., GP of Frazier Life Sciences XII, L.P. |
0002052255 |
| FHMLS XII, L.P. |
0.3% |
223,986 |
0 |
223,986 |
/s/ Gordon Empey |
By Gordon Empey, General Counsel of FHMLS XII, L.L.C., GP of FHMLS XII, L.P. |
0002052246 |
| FHMLS XII, L.L.C. |
0.3% |
223,986 |
0 |
223,986 |
/s/ Gordon Empey |
By Gordon Empey, General Counsel of FHMLS XII, L.L.C. |
0002052177 |
| James N. Topper |
19.9% |
14,429,990 |
98,508 |
14,331,482 |
/s/ Steve R. Bailey |
By Steve R. Bailey, Attorney-in-Fact for James N. Topper, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017 |
0001341382 |
| Patrick J. Heron |
19.9% |
14,346,419 |
14,937 |
14,331,482 |
/s/ Steve R. Bailey |
By Steve R. Bailey, Attorney-in-Fact for Patrick J. Heron, pursuant to a Power of Attorney, a copy of which was filed with the SEC on July 31, 2017 |
0001365617 |
| Albert Cha |
10.1% |
7,270,327 |
0 |
7,270,327 |
/s/ Steve R. Bailey |
By Steve R. Bailey, Attorney-in-Fact for Albert Cha, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021 |
0001397906 |
| James Brush |
10.1% |
7,270,327 |
0 |
7,270,327 |
/s/ Steve R. Bailey |
By Steve R. Bailey, Attorney-in-Fact for James Brush, pursuant to a Power of Attorney, a copy of which was filed with the SEC on August 16, 2021 |
0001865123 |
| Daniel Estes |
1.7% |
1,185,536 |
0 |
1,185,536 |
/s/ Steve R. Bailey |
By Steve R. Bailey, Attorney-in-Fact for Daniel Estes, pursuant to a Power of Attorney, a copy of which was filed with the SEC on April 18, 2022 |
0001702527 |